Clinical Trials Browser

Phase 3 × Completed × Metastatic Hormone-sensitive Prostate Cancer × Clear all

NCT00309985 2025-12-11

CHAARTED

Phase 3 Completed

790 enrolled 11 charts

Metastatic Hormone-sensitive Prostate Cancer